As filed with the Securities and Exchange Commission on August 12, 2022
Registration No. 333-259680
Registration No. 333-255806
Registration No. 333-210774
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Post-Effective Amendment No. 1 to Form S-3, Registration Statement No. 333-259680
Post-Effective Amendment No. 1 to
Form S-3, Registration Statement No. 333-255806
Post-Effective Amendment No. 1 to Form S-3, Registration Statement No. 333-210774
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
Epizyme, Inc.
(Exact
name of registrant as specified in its charter)
|
|
|
Delaware |
|
26-1349956 |
(State or other jurisdiction of
incorporation) |
|
(IRS Employer
Identification No.) |
400 Technology Square, 4th Floor
Cambridge, Massachusetts 02139
(Address, including zip code, of principal executive offices)
Registrants telephone number, including area code: (617) 229-5872
Grant Bogle
Chief
Executive Officer
Epizyme, Inc.
400 Technology Square, 4th Floor
Cambridge, Massachusetts 02139
(617) 229-5872
(Name and address, including zip code, and telephone number, including area code, of agent for service)
With copies to:
|
|
|
Tony Chan, Esq.
Orrick, Herrington & Sutcliffe LLP
Columbia Center 1152 15th
Street, N.W. Washington, DC 20005-1706 |
|
Marsha Mogilevich, Esq.
Orrick, Herrington & Sutcliffe LLP
51 West 52nd Street
New York, NY 10019-6142 |
Approximate date of commencement of proposed sale to the public: Not applicable.
If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following
box: ☐
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to
Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box: ☐
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering. ☐
If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that
shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐
If this form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or
additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of large accelerated
filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.:
|
|
|
|
|
|
|
Large accelerated filer |
|
☒ |
|
Accelerated filer |
|
☐ |
|
|
|
|
Non-accelerated filer |
|
☐ |
|
Smaller reporting company |
|
☐ |
|
|
|
|
|
|
|
|
Emerging growth company |
|
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐